Lung-RADS category 3 means a nodule found on your lung cancer screening CT is “probably benign,” with an estimated 1 to 2 percent chance of being cancer. The standard recommendation is a follow-up low-dose CT scan in six months to check whether the nodule has changed. This is not a cancer diagnosis, and most people with a category 3 result will never need a biopsy or further intervention.
What the Lung-RADS Scale Tells You
Lung-RADS is a scoring system created by the American College of Radiology to standardize how radiologists report lung cancer screening results. It runs from category 1 (no nodules found) through category 4 (suspicious for cancer), with each step reflecting a higher estimated risk of malignancy. Categories 1 and 2 carry less than 1 percent risk. Category 3 sits at 1 to 2 percent. Category 4A jumps to 5 to 15 percent, and category 4B exceeds 15 percent.
The system exists so that every screening center in the country uses the same language and the same follow-up recommendations. When your report says “Lung-RADS 3,” your care team knows exactly what to do next without guesswork.
Which Nodules Get a Category 3
The category depends on two things: the size of the nodule and what it’s made of. Lung nodules fall into three broad types. Solid nodules are dense and clearly visible on a scan. Part-solid nodules have both a dense component and a hazy, cloud-like component. Pure ground-glass nodules look like a faint haze with no solid core at all.
For solid nodules, category 3 generally applies to those measuring roughly 6 to 8 millimeters. Part-solid nodules can land in this category at similar overall sizes depending on how large the solid portion is. Pure ground-glass opacities need to reach at least 20 millimeters before they qualify for category 3, because these hazy nodules are far less likely to be aggressive cancers even at larger sizes. Below that 20-millimeter mark, ground-glass nodules typically fall into category 2 and just need routine annual screening.
What Happens at Your Six-Month Follow-Up
The recommended next step for a category 3 nodule is a repeat low-dose CT scan in six months. This scan uses the same minimal radiation dose as your original screening. Its purpose is simple: to see whether the nodule has grown, shrunk, or stayed the same.
Growth is defined as an increase in average diameter of more than 1.5 millimeters within a 12-month window. That’s a small change, but modern CT scanners can detect it reliably. If the nodule has grown, the category gets upgraded, typically to 4A or 4B depending on how much it changed, and your doctor will recommend closer follow-up or further testing such as a PET scan or biopsy.
If the nodule is stable at three months or longer, the guidelines allow it to be downgraded to category 2. Category 2 means the nodule is considered benign in behavior, carrying less than 1 percent cancer risk, and you can return to routine annual screening. In practice, the median time patients get their follow-up scan is about 161 days, just over five months.
How Often Category 3 Nodules Turn Out to Be Cancer
The official estimate is 1 to 2 percent, but real-world data from clinical practice shows the actual rate can be somewhat higher. A study published in the American Journal of Roentgenology found that 3.9 percent of category 3 nodules (28 out of 712) turned out to be malignant. That’s roughly 1 in 25. Compare that to category 4A at 15.5 percent and category 4B at 36.3 percent, and you can see that category 3 is still firmly on the low-risk end of the spectrum.
The gap between the official 1 to 2 percent estimate and the observed 3.9 percent likely reflects the messiness of real-world medicine. Some nodules that look borderline get classified as category 3 when they might have been called 4A by a different radiologist. Regardless, about 96 percent of people with a category 3 result will not have cancer.
What Could Bump Your Category Up
Several changes on a follow-up scan can push a category 3 nodule into suspicious territory. For solid nodules, reaching 8 millimeters or more moves the classification to 4A. Reaching 15 millimeters or developing rapid growth pushes it to 4B. For part-solid nodules, the key factor is what the solid component does. If the solid portion grows to 6 millimeters or more, the nodule becomes 4A. If it reaches 8 millimeters, that’s 4B.
Slow growth detected across multiple screening exams also triggers an upgrade, even if each individual scan showed only a tiny change. This is why consistent follow-up matters. A nodule that creeps up by a fraction of a millimeter per year can eventually cross the threshold where further evaluation is warranted.
Why Following Up on Time Matters
Research shows that adherence to recommended follow-up for category 3 nodules is lower than it should be. People who are currently smoking are about half as likely to get their six-month scan compared to those who have quit. Black individuals and men also tend to have lower follow-up rates. These gaps matter because the entire point of the screening program is catching cancer early, and a category 3 result only works as a safety net if you actually return for the next scan.
If your nodule is stable at follow-up, you’re back to annual screening with very low risk. If it has grown, catching that growth at six months rather than a year or two later could mean the difference between a small, treatable cancer and something more advanced. The six-month window is carefully chosen to balance avoiding unnecessary anxiety with catching real changes early enough to act on them.